公司文献
智核的研发团队在具有重要影响力的期刊上发表研究论文多篇。多篇SNA002的相关研究成果在核医学科最高水平的期刊Journal of Nuclear Medicine得到认可。 
09a1af23b863c611f32e346d72f05cb
3862a91d2e83be1ec3befccb1024390
4100e7f67aa7643fc0b125326274c4b
065e5c6ce858e48bd4b7ab681cd96fe
ce5465dc8fdcff52dfa93eb61b6b74c
文献发表
PET imaging of tumor PD-L1 expression with a highly specific non-blocking nanobody             
Journal of Nuclear Medicine, published on June 28, 2019 as doi:10.2967/jnumed.119.226712

ImmunoPET imaging of human CD8+ T cells with novel 68Ga‑labeled nanobody companion diagnostic agents
Journal of Nanobiotechnology   doi.org/10.1186/s12951-021-00785-9

Immuno-PET imaging of 68Ga-labeled nanobody Nb109 for dynamic monitoring the PD-L1 expression in cancers

Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma
Front. Endocrinol., 17 February 2021 | https://doi.org/10.3389/fendo.2020.615883

Lipidomic Perturbations in Cynomolgus Monkeys are Regulated by Thyroid Stimulating Hormone

Front. Mol. Biosci., 15 March 2021 | https://doi.org/10.3389/fmolb.2021.640387

A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with 68Ga-labeled PD-L1 targeted nanobody